Cosyntropin impurities are unwanted substances that can be present in synthetic adrenocorticotropic hormone (ACTH) medication. These impurities can affect the purity and potency of the medication, potentially leading to negative side effects or reduced effectiveness. It is important for pharmaceutical companies to closely monitor and control the levels of impurities in their Cosyntropin products to ensure they meet strict quality and safety standards.